Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 1415119-52-6, Ovr52k7bdw, Odalasvir (ach-3102), Ach-3102, Ach-0143102, Carbamic acid, n,n'-(tricyclo(8.2.2.24,7)hexadeca-4,6,10,12,13,15-hexaene-5,11-diylbis(1h-benzimidazole-6,2-diyl((2s,3as,7as)-octahydro-1h-indole-2,1-diyl)((1s)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-, c,c'-dimethyl ester
Molecular Formula
C60H72N8O6
Molecular Weight
1001.3  g/mol
InChI Key
LSYBRGMTRKJATA-IVEWBXRVSA-N
FDA UNII
OVR52K7BDW

Odalasvir has been used in trials studying the treatment of Hepatitis C, Chronic and Chronic Hepatitis C Infection.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
methyl N-[(2S)-1-[(2S,3aS,7aS)-2-[6-[11-[2-[(2S,3aS,7aS)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-2-yl]-3H-benzimidazol-5-yl]-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
2.1.2 InChI
InChI=1S/C60H72N8O6/c1-33(2)53(65-59(71)73-5)57(69)67-49-13-9-7-11-41(49)31-51(67)55-61-45-25-23-39(29-47(45)63-55)43-27-35-15-19-37(43)21-17-36-16-20-38(22-18-35)44(28-36)40-24-26-46-48(30-40)64-56(62-46)52-32-42-12-8-10-14-50(42)68(52)58(70)54(34(3)4)66-60(72)74-6/h15-16,19-20,23-30,33-34,41-42,49-54H,7-14,17-18,21-22,31-32H2,1-6H3,(H,61,63)(H,62,64)(H,65,71)(H,66,72)/t41-,42-,49-,50-,51-,52-,53-,54-/m0/s1
2.1.3 InChI Key
LSYBRGMTRKJATA-IVEWBXRVSA-N
2.1.4 Canonical SMILES
CC(C)C(C(=O)N1C2CCCCC2CC1C3=NC4=C(N3)C=C(C=C4)C5=C6CCC7=CC(=C(CCC(=C5)C=C6)C=C7)C8=CC9=C(C=C8)N=C(N9)C1CC2CCCCC2N1C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC
2.1.5 Isomeric SMILES
CC(C)[C@@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C3=NC4=C(N3)C=C(C=C4)C5=C6CCC7=CC(=C(CCC(=C5)C=C6)C=C7)C8=CC9=C(C=C8)N=C(N9)[C@@H]1C[C@@H]2CCCC[C@@H]2N1C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC
2.2 Other Identifiers
2.2.1 UNII
OVR52K7BDW
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ach-3102

2.3.2 Depositor-Supplied Synonyms

1. 1415119-52-6

2. Ovr52k7bdw

3. Odalasvir (ach-3102)

4. Ach-3102

5. Ach-0143102

6. Carbamic Acid, N,n'-(tricyclo(8.2.2.24,7)hexadeca-4,6,10,12,13,15-hexaene-5,11-diylbis(1h-benzimidazole-6,2-diyl((2s,3as,7as)-octahydro-1h-indole-2,1-diyl)((1s)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-, C,c'-dimethyl Ester

7. Dimethyl N,n'-(1,4(1,4)-dibenzenacyclohexaphane-12,42-diylbis(1hbenzimidazole-5,2-diyl((2s,3as,7as)-octahydro-1h-indole-2,1-diyl)((2s)-3-methyl-1-oxobutan-1,2-diyl)))biscarbamate

8. Dimethyl ((2s,2's)-((2s,2's,3as,3a's,7as,7a's)-(1,4(1,4)-dibenzenacyclohexaphane-12,43-diylbis(1h-benzo[d]imidazole-6,2-diyl))bis(octahydro-1h-indole-2,1-diyl))bis(3-methyl-1-oxobutane-1,2-diyl))dicarbamate

9. Methyl N-[(2s)-1-[(2s,3as,7as)-2-[6-[11-[2-[(2s,3as,7as)-1-[(2s)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-2-yl]-3h-benzimidazol-5-yl]-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1h-benzimidazol-2-yl]-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

10. Odalasvir [usan:inn]

11. Unii-ovr52k7bdw

12. Odalasvir [inn]

13. Odalasvir [usan]

14. Odalasvir [who-dd]

15. Chembl3544977

16. Schembl14122808

17. Schembl18685009

18. Schembl19236067

19. Dtxsid401032258

20. Db13041

21. Q4650666

2.4 Create Date
2013-06-10
3 Chemical and Physical Properties
Molecular Weight 1001.3 g/mol
Molecular Formula C60H72N8O6
XLogP311.5
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count8
Rotatable Bond Count12
Exact Mass1000.55748205 g/mol
Monoisotopic Mass1000.55748205 g/mol
Topological Polar Surface Area175 Ų
Heavy Atom Count74
Formal Charge0
Complexity1840
Isotope Atom Count0
Defined Atom Stereocenter Count8
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antiviral Agents

Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)